Clinical trial
Intensity Modulated Versus Interstitial - Radiation Therapy
NCT00407875 · British Columbia Cancer Agency, Other · Unknown status
Key facts
| NCT number | NCT00407875 |
|---|---|
| Title | Intensity Modulated Versus Interstitial - Radiation Therapy |
| Official title | A Randomized Phase II Study Comparing Intensity Modulated External Beam Radiation Therapy (IMRT) Versus Permanent Interstitial Prostate Brachytherapy (PIPB) for Low Risk and Low-tier Intermediate Risk Prostate Cancer |
| Lead sponsor | British Columbia Cancer Agency, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | Intensity Modulated External Beam Radiation Therapy |
| Enrollment | 50 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2020 |
| First posted | Dec 5, 2006 |
| Last update posted | Jul 13, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: